From farming and extraction in Tasmania to FDA audited, cGMP production facilities in the United States and Europe, Noramco offers an unrivaled supply chain for high-purity controlled substance and opiate-derived APIs. Building on four decades of expertise in natural and synthetic API technology, we continuously strive to meet our customers’ requirements and accelerate their speed to market.

Noramco’s API value offering includes, but is not limited to:

  • Direct access to high-purity narcotic raw materials
  • Expertise and IP for efficient high-purity API manufacture
  • Capability to produce multiple particle size grades to meet various dosage form requirements
  • An expanding list of controlled substance APIs
  • Exemplary FDA, EDQM, and DEA compliance records for controlled substances, from schedule I to schedule III